New Generics Need To Influence Medicare Rates More Quickly – OIG

Health and Human Services' Office of Inspector General is calling on the Centers for Medicare and Medicaid Services to more quickly adjust reimbursement rates for Medicare Part B drugs when low-priced generics enter the market